Abstract
The human immunodeficiency virus type 1 (HIV-1) encodes a protein, called Vpr, that prevents proliferation of infected cells by arresting them in G2 of the cell cycle. This Vpr-mediated cell-cycle arrest is also conserved among highly divergent simian immunodeficiency viruses, suggesting an important role in the virus life cycle. However, it has been unclear how this could be a selective advantage for the virus. Here we provide evidence that expression of the viral genome is optimal in the G2 phase of the cell cycle, and that Vpr increases virus production by delaying cells at the point of the cell cycle where the long terminal repeat (LTR) is most active. Although Vpr is selected against when virus is adapted to tissue culture, we show that selection for Vpr function in vivo occurs in both humans and chimpanzees infected with HIV-1. These results suggest a novel mechanism for maximizing virus production in the face of rapid killing of infected target cells.
Similar content being viewed by others
References
Suzuki, T., Kitao, S., Matsushime, H. & Yoshida, M. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p1 6INK4A and counteracts its inhibitory activity towards CDK4. EMBO J. 15, 1607–1614 (1996).
Moran, E. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3, 63–70 (1993).
Nevins, J.R. Adenovirus E1A: Transcription regulation and alteration of cell growth control. Curr. Top. Microbiol. Immunol. 199, 25–32 (1995).
Cayrol, C. & Flemington, E.K. Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15, 2748–2759 (1996).
Lu, M. & Shenk, T. Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J. Virol. 70, 8850–8857 (1996).
Emerman, M. HIV-1, Vpr and the cell cycle. Curr. Biol. 6, 1096–1103 (1996).
Bartz, S., Rogel, M.E. & Emerman, M. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70, 2324–2331 (1996).
He, J., et al. Human immunodeficiency virus type 1 protein R (Vpr) blocks cells in the G2 phase of the cell cycle by inhibiting p34dcd2 activity. J. Virol. 69, 6705–6711 (1995).
Jowett, J.B.M., et al. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69, 6304–6313 (1995).
Re, F., Braaten, D., Franke, E.K. & Luban, J. Human immunodeficiency virus type 1 arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclinB. J. Virol. 69, 6859–6864 (1995).
Planelles, V. et al. Fate of the human immunodeficiency virus type 1 provirus in infected cells: A role for Vpr. J. Virol. 69, 5883–5889 (1995).
Rogel, M., Wu, L. & Emerman, M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69, 882–888 (1995).
Sharp, P.M., Bailes, E., Stevenson, M., Emerman, M. & Hahn, B.H. Gene acquisition in HIV and SIV. Nature 383, 586–587 (1996).
Stivahtis, G.L., Soares, M.A., Vodicka, M.A., Hahn, B.H. & Emerman, M. Conservation and host specificity of Vpr− mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J. Virol. 71, 4331–4338 (1997).
Planelles, V., et al. Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70, 2516–2524 (1996).
Wei, X., et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117–122 (1995).
Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M. & Ho, D.D. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582–1585 (1996).
Ho, D.D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123–126 (1995).
Cohen, E.A., et al. Identification of HIV-1 Vpr product and function. J. Acquir. Immune Defic. Syndr. 3, 11–18 (1990).
Agostini, I., et al. The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB. J. Mol. Biol. 261, 599–606 (1996).
Wang, L., Mukherjee, S., Jia, F., Narayan, O. & Zhao, L.J. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and transactivation of viral long terminal repeat. J. Biol. Chem. 270, 25564–25569 (1995).
Selig, L. et al. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest. J. Virol. 71, 4842–4846 (1997).
van den Heuvel, S. & Harlow, E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262, 2050–2054 (1993).
Gibbs, J.S. et al. Progression to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69, 2378–2383 (1995).
Hoch, J. et al. vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys, J. Virol. 69, 4807–4813 (1995).
Aldrovandi, G.M. & Zack, J.A. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J. Virol. 70, 1505–1511 (1996).
Weiss, S.H., et al. Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science 239, 68–71 (1988).
Reitz, M.S., Jr., et al. Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB). AIDS Res. Hum. Retrovir. 10, 1143–1155 (1994).
Fultz, P.N., et al. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science 256, 1687–1690 (1992).
Myers, G., et al. Human Retroviruses and AIDS. (Los Alamos National Laboratory, Los Alamos, NM, 1994).
Stewart, S.A., Poon, B., Jowett, J.B. & Chen, I.S. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71, 5579–5592 (1997).
Nakaya, T., et al. Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carrier-derived peripheral blood mononuclear cells. FEBS Lett. 354, 17–22 (1994).
Uchiumi, T., Longo, D.L. & Ferris, D.K. Cell cycle regulation of the human polo-like kinase (Plk) promoter. J. Biol. Chem. 272, 9166–9174 (1997).
Zwicker, J. et al. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J. 14, 4514–4522 (1995).
Fletcher, T.M. et al. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIVSM. EMBO J. 15, 6155–6165 (1996).
Lang, S.M. et al. Importance of Vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67, 902–912 (1993).
Kimpton, J. & Emerman, M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66, 2232–2239 (1992).
Piatak, M. Jr., Luk, K.C., Williams, B. & Lifson, J.D. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques 14, 70–81 (1993).
O'Connor, P.M. et al. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J. Biol. Chem. 268, 8298–8308 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goh, W., Rogel, M., Kinsey, C. et al. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo. Nat Med 4, 65–71 (1998). https://doi.org/10.1038/nm0198-065
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0198-065
- Springer Nature America, Inc.
This article is cited by
-
An insight on promising strategies hoping to cure HIV-1 infection by targeting Rev protein—short review
Pharmacological Reports (2021)
-
Viral protein R polymorphisms in the pathogenesis of HIV-associated acute ischaemic stroke: a case–control study
Journal of NeuroVirology (2021)
-
Impact of HIV-1 Vpr manipulation of the DNA repair enzyme UNG2 on B lymphocyte class switch recombination
Journal of Translational Medicine (2020)
-
Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex
Nature Microbiology (2018)
-
Spontaneous reactivation of latent HIV-1 promoters is linked to the cell cycle as revealed by a genetic-insulators-containing dual-fluorescence HIV-1-based vector
Scientific Reports (2018)